947 related articles for article (PubMed ID: 23564537)
1. Further experience with the "no-react" bioprosthesis in patients with active infective endocarditis: 11-year single center results in 402 patients.
Musci M; Amiri A; Siniawski H; Stein J; Weng Y; Hetzer R
Thorac Cardiovasc Surg; 2013 Aug; 61(5):398-408. PubMed ID: 23564537
[TBL] [Abstract][Full Text] [Related]
2. Surgical therapy in patients with active infective endocarditis: seven-year single centre experience in a subgroup of 255 patients treated with the Shelhigh stentless bioprosthesis.
Musci M; Siniawski H; Pasic M; Weng Y; Loforte A; Kosky S; Yankah C; Hetzer R
Eur J Cardiothorac Surg; 2008 Aug; 34(2):410-7. PubMed ID: 18579396
[TBL] [Abstract][Full Text] [Related]
3. Homograft aortic root replacement in native or prosthetic active infective endocarditis: twenty-year single-center experience.
Musci M; Weng Y; Hübler M; Amiri A; Pasic M; Kosky S; Stein J; Siniawski H; Hetzer R
J Thorac Cardiovasc Surg; 2010 Mar; 139(3):665-73. PubMed ID: 19767017
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of aortic root abscess: a 13-year experience in 172 patients with 100% follow-up.
Leontyev S; Borger MA; Modi P; Lehmann S; Seeburger J; Doenst T; Mohr FW
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):332-7. PubMed ID: 21724196
[TBL] [Abstract][Full Text] [Related]
5. Early outcome after surgery for active native and prosthetic aortic valve endocarditis.
Gabbieri D; Dohmen PM; Linneweber J; Grubitzsch H; von Heymann C; Neumann K; Halle E; Konertz WF
J Heart Valve Dis; 2008 Sep; 17(5):508-24; discussion 525. PubMed ID: 18980085
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience.
Musci M; Siniawski H; Pasic M; Grauhan O; Weng Y; Meyer R; Yankah CA; Hetzer R
Eur J Cardiothorac Surg; 2007 Jul; 32(1):118-25. PubMed ID: 17412606
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of infective mitral valve endocarditis: predictors of early and late outcome.
Alexiou C; Langley SM; Stafford H; Haw MP; Livesey SA; Monro JL
J Heart Valve Dis; 2000 May; 9(3):327-34. PubMed ID: 10888086
[TBL] [Abstract][Full Text] [Related]
8. Surgery for active infective mitral valve endocarditis: a 20-year, single-center experience.
Musci M; Hübler M; Pasic M; Amiri A; Stein J; Siniawski H; Weng Y; Hetzer R
J Heart Valve Dis; 2010 Mar; 19(2):206-14; discussion 215. PubMed ID: 20369505
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and prognosis of patients requiring valve surgery during active infective endocarditis.
Fayad G; Leroy G; Devos P; Hervieux E; Senneville E; Koussa M; Leroy O
J Heart Valve Dis; 2011 Mar; 20(2):223-8. PubMed ID: 21560826
[TBL] [Abstract][Full Text] [Related]
10. Outcome after surgery for prosthetic valve endocarditis and the impact of preoperative treatment.
Grubitzsch H; Schaefer A; Melzer C; Wernecke KD; Gabbieri D; Konertz W
J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2052-9. PubMed ID: 24951022
[TBL] [Abstract][Full Text] [Related]
11. Aortic valve replacement for endocarditis: determinants of early and late outcome.
Langley SM; Alexiou C; Stafford HM; Dalrymple-Hay MJ; Haw MP; Livesey SA; Monro JL
J Heart Valve Dis; 2000 Sep; 9(5):697-704. PubMed ID: 11041187
[TBL] [Abstract][Full Text] [Related]
12. Surgical Treatment for Infective Endocarditis: A Single-Centre Experience.
Perrotta S; Jeppsson A; Fröjd V; Svensson G
Thorac Cardiovasc Surg; 2017 Apr; 65(3):166-173. PubMed ID: 27074494
[No Abstract] [Full Text] [Related]
13. Long-term results of operation for paravalvular abscess.
d'Udekem Y; David TE; Feindel CM; Armstrong S; Sun Z
Ann Thorac Surg; 1996 Jul; 62(1):48-53. PubMed ID: 8678685
[TBL] [Abstract][Full Text] [Related]
14. Stentless bioprostheses: a versatile and durable solution in extensive aortic valve endocarditis.
Schneider AW; Hazekamp MG; Versteegh MI; Bruggemans EF; Holman ER; Klautz RJ; Braun J
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1699-704. PubMed ID: 26792920
[TBL] [Abstract][Full Text] [Related]
15. Tricuspid valve replacement: bioprostheses are preferable.
Dalrymple-Hay MJ; Leung Y; Ohri SK; Haw MP; Ross JK; Livesey SA; Monro JL
J Heart Valve Dis; 1999 Nov; 8(6):644-8. PubMed ID: 10616242
[TBL] [Abstract][Full Text] [Related]
16. Aortic valve endocarditis. Determinants of early survival and late morbidity.
Aranki SF; Santini F; Adams DH; Rizzo RJ; Couper GS; Kinchla NM; Gildea JS; Collins JJ; Cohn LH
Circulation; 1994 Nov; 90(5 Pt 2):II175-82. PubMed ID: 7955248
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of surgery in the treatment of isolated nonnative mitral valve infective endocarditis.
Greason KL; Thomas M; Steckelberg JM; Daly RC; Schaff HV; Li Z; Dearani JA
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):349-54. PubMed ID: 23317945
[TBL] [Abstract][Full Text] [Related]
18. Infective endocarditis of native cardiac valves: 22 years' surgical experience.
Cotrufo M; Carozza A; Romano G; De Feo M; Della Corte A
J Heart Valve Dis; 2001 Jul; 10(4):478-85. PubMed ID: 11499594
[TBL] [Abstract][Full Text] [Related]
19. Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis.
Fedoruk LM; Jamieson WR; Ling H; Macnab JS; Germann E; Karim SS; Lichtenstein SV
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):326-33. PubMed ID: 19185146
[TBL] [Abstract][Full Text] [Related]
20. Aortic valve replacement for active infectious endocarditis in 108 patients. A comparison of freehand allograft valves with mechanical prostheses and bioprostheses.
Haydock D; Barratt-Boyes B; Macedo T; Kirklin JW; Blackstone E
J Thorac Cardiovasc Surg; 1992 Jan; 103(1):130-9. PubMed ID: 1728698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
